The Lancet 2023 trial in patients with type 2 diabetes reported approximately 16.9% mean weight loss in the highest dose group at 36 weeks alongside significant HbA1c reductions, demonstrating that the weight loss effect persists in the presence of diabetes and concurrent glucose-lowering effects
Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery
Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition.
These groups are more at risk because their bodies need more B12
The co-injection ensures that the B6 reaches systemic circulation at the same time as the semaglutide, providing nausea coverage right when it is most needed
PLoS One 2 (3), e334